Biblio

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

G

Omori S, Wang T-W, Johmura Y, Kanai T, Nakano Y, Kido T, Susaki EA, Nakajima T, Shichino S, Ueha S, et al. Generation of a p16 Reporter Mouse and Its Use to Characterize and Target p16 Cells In Vivo. Cell Metab. 2020.

Zhang M, Ibañez DP, Fan W, Liu H, Zhong X, Wang X, Li Y, Abdul MMd, Li W, Li Y, et al. Generation of a PARK2 homozygous knockout induced pluripotent stem cell line (GIBHi002-A-1) with two common isoforms abolished. Stem Cell Res. 2019;41:101602.

Kim B-Y, Ko JMin, Park M-H, Koo SKyung. Generation of a patient-specific induced pluripotent stem cell line, KSCBi006-A, for osteogenesis imperfecta type I with the COL1A1, c.3162delT mutation. Stem Cell Res. 2019;41:101622.

Geryk M, Canac R, Forest V, Lindenbaum P, Girardeau A, Baudic M, Baron E, Bibonne A, Chariau C, Kyndt F, et al. Generation of a patient-specific induced pluripotent stem cell line carrying the DES p.R406W mutation, an isogenic control and a DES p.R406W knock-in line. Stem Cell Res. 2024;77:103396.

Djemai M, Jauvin D, Poulin H, Chapotte-Baldacci C-A, Chahine M. Generation of a patient-specific iPSC cell line with cardiac arrhythmias and dilated cardiomyopathy (CBRCULi016-A), an isogenic control (CBRCULi016-A-1), and a paternal control (CBRCULi017-A). Stem Cell Res. 2024;75:103308.

Jo S, Kim J-W, Noh H, Kim H, Kim J-H, Park H-J. Generation of a PDGFRB-mCherry knock-in reporter human induced pluripotent stem cell line (KITi001-A-1), using CRISPR/Cas9 nuclease. Stem Cell Res. 2023;69:103081.

Lee Y, Choi HYoung, Kwon A, Park H, Park M-H, Kim J-W, Kim MJung, Kim Y-O, Kwak S, Koo SKyung. Generation of a PDX1-EGFP reporter human induced pluripotent stem cell line, KSCBi005-A-3, using the CRISPR/Cas9 system. Stem Cell Res. 2019;41:101632.

Maurer W, Rebs S, Köhne S, Eberl H, Wollnik B, Zibat A, Streckfuss-Bömeke K. Generation of a pluripotent stem cell line (UMGi270-A) and a corresponding CRISPR/Cas9 modified isogenic control (UMGi270-A-1) from a patient with sudden onset dilated cardiomyopathy harboring a FLNC p.R2187P mutation. Stem Cell Res. 2024;77:103409.

Guo X, Zhao K, Zhang Y, Zhou T, Pan G. Generation of a PPM1A-deficient human induced pluripotent stem cell line using CRISPR-Cas9 technology. Stem Cell Res. 2024;77:103420.

Wang X, Sun J, Fu C, Liu C. Generation of a PPP1CA knockout human pluripotent stem cell line via CRISPR/Cas9. Stem Cell Res. 2023;69:103077.

Haridhasapavalan KKumar, Sundaravadivelu PKumar, Joshi N, Das NJyoti, Mohapatra A, Voorkara U, Kaveeshwar V, Thummer RP. Generation of a recombinant version of a biologically active cell-permeant human HAND2 transcription factor from E. coli. Sci Rep. 2022;12(1):16129.

Lorthongpanich C, Laowtammathron C, Jiamvoraphong N, Srisook P, Chingsuwanrote P, Klaihmon P, Waeteekul S, U-Pratya Y, Issaragrisil S. Generation of a serine/threonine-protein kinase LATS1 gene-edited iPSC MUSIi012-A-3. Stem Cell Res. 2020;48:101950.

Jung M, Hartmann C, Ehrhardt T, Peter L-M, Abid CLuqman, Harwardt B, Hirschfeld J, Claus C, Haferkamp U, Pless O, et al. Generation of a set of induced pluripotent stem cell lines from two Alzheimer disease patients carrying APOE4 (MLUi007-J; MLUi008-A) and healthy old donors carrying APOE3 (MLUi009-A; MLUi010-B) to study APOE in aging and disease. Stem Cell Res. 2023;69:103072.

Schmid B, Prehn KR, Nimsanor N, Garcia BIrene Alda, Poulsen U, Jørring I, Rasmussen MA, Clausen C, Mau-Holzmann UA, Ramakrishna S, et al. Generation of a set of isogenic, gene-edited iPSC lines homozygous for all main APOE variants and an APOE knock-out line. Stem Cell Res. 2019;34:101349.

Schmid B, Holst B, Clausen C, Bahnassawy L, Reinhardt P, Bakker MHM, Díaz-Guerra E, Vicario C, Martino-Adami PV, Thoenes M, et al. Generation of a set of isogenic iPSC lines carrying all APOE genetic variants (Ɛ2/Ɛ3/Ɛ4) and knock-out for the study of APOE biology in health and disease. Stem Cell Res. 2021;52:102180.

Zhang W, Di W, Zhao J, Zhang B, Wang Y. Generation of a SIAISi004-A hiPSC line from PBMCs of a 74 year-old Alzheimer's disease woman by non-integrating sendai virus mediated reprogramming. Stem Cell Res. 2021;55:102501.

Gu J, Rollo B, Geza B, Steven P, Kwan P, Sumer H, Brett C. Generation of a stably transfected mouse embryonic stem cell line for inducible differentiation to excitatory neurons. Exp Cell Res. 2023:113902.

Sun W, Li X, Dong J, Zhou Y. Generation of a TAB2 knockout hESC line (WAe009-A-Z) derived from H9 using CRISPR/Cas9. Stem Cell Res. 2023;74:103284.

Yan J, Sultana N, Zhang L, Park DS, Shekhar A, Hu J, Bu L, Cai C-L. Generation of a tamoxifen inducible Tnnt2(MerCreMer) knock-in mouse model for cardiac studies. Genesis. 2015.

Hou X, Mu J. Generation of a TBX20 homozygous knockout stem cell line (WAe009-A-1E) by episomal vector-based CRISPR/Cas9 system. Stem Cell Res. 2024;77:103384.

Wu X, Wang X. Generation of a TBX20-knockout human embryonic stem line by CRISPR/Cas9 system. Stem Cell Res. 2023;69:103082.

Zhao T, Bai R, Wu F, Lu W-J, Zhang J. Generation of a TBX5 homozygous knockout embryonic stem cell line (WAe009-A-45) by CRISPR/Cas9 genome editing. Stem Cell Res. 2021;51:102156.

Zhao H, He L, Huang H, Li S, Cheng N, Tang F, Han X, Lin Z, Huang R, Zhou P, et al. Generation of a tdTomato-GAD67 reporter human epilepsia mutation induced pluripotent stem cell line, USTCi001-A-2, using CRISPR/Cas9 editing. Stem Cell Res. 2020;48:102003.

Getachew A, Yang Z, Huang X, Wu F, Liu YYing, Yan C, Yang F, Li Y. Generation of a TLR2 homozygous knockout human embryonic stem cell line WAe001-A-64 using CRISPR/Cas9 editing. Stem Cell Res. 2021;54:102401.

Han H-J, Kim J-H. Generation of a TLR2 knockout human induced pluripotent stem cell line using CRISPR/Cas9. Stem Cell Res. 2021;57:102578.

Pages